Secondary primary lung cancer after esophageal cancer: a population-based study of 44,172 patients

References

• Mitani S, Kadowaki S, Oze I, et al. Risk of second primary malignancies after definitive treatment for esophageal cancer: a competing risk analysis. Cancer Med. 2020;9(1):394–400.
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
   PubMed Web of Science ®Google Scholar
• Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975–2014, Featuring survival. J Natl Cancer Inst. 2017;109(9): djx030.
   PubMedGoogle Scholar
• Nandy N, Dasanu CA. Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review. Curr Med Res Opin. 2013;29(9):1055–1065.
   PubMed Web of Science ®Google Scholar
• Zhu G, Chen Y, Zhu Z, et al. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries. Dis Esophagus. 2012;25(6):505–511.
   PubMed Web of Science ®Google Scholar
• Chen SC, Teng CJ, Hu YW, et al. Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: a nationwide population-based study. PLoS One. 2015;10(1):e0116384.
   PubMed Web of Science ®Google Scholar
• Chuang SC, Hashibe M, Scelo G, et al. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev. 2008;17(6):1543–1549.
   PubMed Web of Science ®Google Scholar
• Matsubara T, Yamada K, Nakagawa A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003;21(23):4336–4341.
   PubMed Web of Science ®Google Scholar
• Ohashi S, Miyamoto S, Kikuchi O, et al. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology. 2015;149(7):1700–1715.
   PubMed Web of Science ®Google Scholar
• Fox AJ. Statistical methods in cancer research: volume 2. The design and analysis of cohort studies. IARC Sci Publ. 1987;82(82):1.
   Google Scholar
• White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–399.
   PubMed Web of Science ®Google Scholar
• Voigt L, Ullrich A, Baumann S, et al. Do sociodemographic variables and cardiometabolic risk factors moderate the mere-measurement effect on physical activity and sedentary time? BMC Cardiovasc Disord. 2020;20(1):272.
   PubMed Web of Science ®Google Scholar
• Lee JS, Ahn JY, Choi KD, et al. Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome. Korean J Intern Med. 2016;31(2):253–259.
   PubMed Web of Science ®Google Scholar
• Kudou M, Shiozaki A, Fujiwara H, et al. Clinical analysis of esophageal cancer patients with a history of metachronous primary cancer. Gan to Kagaku Ryoho. 2014;41(12):2030–2032.
   PubMedGoogle Scholar
• Budnik J, DeNunzio NJ, Singh DP, et al. Second primary non-small-cell lung cancer after head and neck cancer: a population-based study of clinical and pathologic characteristics and survival outcomes in 3597 patients [published correction appears in clin lung cancer. Clin Lung Cancer. 2020;21(3):195–203.
   PubMed Web of Science ®Google Scholar
• Milano MT, Strawderman RL, Venigalla S, et al. Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women. J Thorac Oncol. 2014;9(8):1081–1090.
   PubMed Web of Science ®Google Scholar
• Hoskin TL, Boughey JC, Day CN, et al. Lessons learned regarding missing clinical stage in the national cancer database. Ann Surg Oncol. 2019;26(3):739–745.
   PubMed Web of Science ®Google Scholar
• Cook MB, Hurwitz LM, Geczik AM, et al. An up-to-date assessment of US prostate cancer incidence rates by stage and race: a novel approach combining multiple imputation with age and delay adjustment. Eur Urol. 2021;79(1):33–41.
   PubMed Web of Science ®Google Scholar
• Wagner MJ, Chau B, Loggers ET, et al. Long-term outcomes for extraskeletal myxoid chondrosarcoma: a SEER database analysis. Cancer Epidemiol Biomarkers Prev. 2020;29(11):2351–2357.
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Miller KD, Goding Sauer A, et al. Cancer statistics for African Americans, 2019. CA A Cancer J Clin. 2019;69(3):211–233.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Thakur MK, Ruterbusch JJ, Schwartz AG, et al. Risk of second lung cancer in patients with previously treated lung cancer: analysis of surveillance, epidemiology, and end results (SEER) data. J Thorac Oncol. 2018;13(1):46–53.
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review. 1975–2012 [cited 2017 Mar 20]. Available from: http://seer.cancer.gov/csr/1975_2012/.
   Google Scholar
• Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol. 2007;25(35):5570–5577.
   PubMed Web of Science ®Google Scholar
• Ushijima T. Epigenetic field for cancerization. J Biochem Mol Biol. 2007;40(2):142–150.
   PubMedGoogle Scholar
• Baba Y, Yoshida N, Kinoshita K, et al. Clinical and prognostic features of patients with esophageal cancer and multiple primary cancers: a retrospective single-institution study. Ann Surg. 2018;267(3):478–483.
   PubMed Web of Science ®Google Scholar
• Katada C, Yokoyama T, Yano T, et al. Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck. Gastroenterology. 2016;151(5):860–869.e7.
   PubMed Web of Science ®Google Scholar
• Guan Y, Wang G, Fails D, et al. Unraveling cancer lineage drivers in squamous cell carcinomas. Pharmacol Ther. 2020;206:107448.
   PubMed Web of Science ®Google Scholar
• Ye Y, Otahal P, Wills KE, et al. Temporal trends in the risk of second primary cancers among survivors of adult-onset cancers, 1980 through 2013: an Australian population-based study. Cancer. 2018;124(8):1808–1818.
   PubMed Web of Science ®Google Scholar
• Corkum M, Hayden JA, Kephart G, et al. Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis. J Cancer Surviv. 2013;7(3):455–463.
   PubMed Web of Science ®Google Scholar
• Wang R, Yin Z, Liu L, et al. Second primary lung cancer after breast cancer: a population-based study of 6,269 women. Front Oncol. 2018;8:427.
   PubMed Web of Science ®Google Scholar
• Veit-Rubin N, Rapiti E, Usel M, et al. Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma. Oncologist. 2012;17(6):783–791.
   PubMed Web of Science ®Google Scholar